Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.

Amanda L Woerman1,2, Sabeen A Kazmi1, Smita Patel1

  • 1Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, CA 94158.

Proceedings of the National Academy of Sciences of the United States of America
|December 28, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of severe disease in granulomatous lymphocytic interstitial lung disease: a retrospective cohort study.

ERJ open research·2026
Same author

High-Throughput Screening Identifies Small-Molecule Inhibitors of the Tau-LRP1 Interaction.

bioRxiv : the preprint server for biology·2026
Same author

Select microbial metabolites promote tau aggregation in a murine tauopathy model.

Nature communications·2026
Same author

Author Correction: High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.

Nature chemistry·2026
Same author

Adaptation of α-synuclein fibrils following multiple system atrophy transmission to mice.

bioRxiv : the preprint server for biology·2026
Same author

Biased signaling at NTSR1 differentially regulates inhibitory synaptic transmission in the extended amygdala and suppresses motivated feeding in mice.

bioRxiv : the preprint server for biology·2026

Multiple system atrophy (MSA) and Parkinson's disease (PD) involve misfolded alpha-synuclein. MSA prions infect cells except those with the E46K mutation, indicating distinct conformations and potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the misfolding of alpha-synuclein into a prion form.
  • Parkinson's disease (PD) also involves alpha-synuclein pathology, with specific genetic mutations linked to inherited forms of the disease.

Purpose of the Study:

  • To compare the biological activity of alpha-synuclein prions in MSA with those associated with Parkinson's disease.
  • To investigate the role of specific alpha-synuclein mutations in prion replication and conformational differences.

Main Methods:

  • Development of nine alpha-synuclein-YFP cell lines expressing point mutations associated with inherited PD.
  • Infection of these cell lines with MSA prions to assess replication efficiency.
Keywords:
neurodegenerationproteinopathystrainssynucleinopathiesα-synuclein

Related Experiment Videos

  • Evaluation of prion replication in wild-type, A30P, A53T, and E46K mutant alpha-synuclein-YFP cells, as well as coexpression models.
  • Main Results:

    • MSA prions robustly infected wild-type, A30P, and A53T alpha-synuclein-YFP cells.
    • Replication of MSA prions was completely inhibited in cells expressing the E46K mutation.
    • Coexpression of A53T and E46K mutations did not rescue MSA prion infection, confirming distinct conformational properties.

    Conclusions:

    • MSA alpha-synuclein prions exhibit distinct conformational properties compared to misfolded alpha-synuclein found in Parkinson's disease.
    • The E46K mutation confers resistance to MSA prion infection, highlighting its unique structural characteristics.
    • These findings have significant implications for understanding disease mechanisms and developing targeted therapies for neurodegenerative diseases like MSA and PD.